Researchers in cancer and oncologists advertise “clear clearance” and “adequate funding” for Personalized Medicine

MADRID, 21 Abr. (EUROPE PRESS) –

The Spanish Association for Research on Cancer (ASEICA) and the Spanish Society of Medical Oncology (SEOM) are advertising, the motivation of Día de la Innovación en Cáncer, a “clear clearance” of the authorities and “adequate funding” to implant the Personalized in all of Spain.

“The development of personalized medicine and precision is undergoing a revolution on the day of the attention of patients with cancer. The diagnosis of patients. It is also necessary to send the basics in order for this new form of medical treatment to be in an efficient and fully accessible way for all patients. For this, active policies are needed by central authorities as well as a financial center. which supports the investigation into this camp and its application to the clinical ward “, he complained the president of ASEICA, Luis Paz- Ares, and the president of SEOM, Álvaro Rodríguez-Lescure, these Wednesday in a row of princes.

The two experts coincided with signaling the need to innovate the patient through a Personalized Medicine plan and precision such as the tenure of our entourage. “Incorporate into the framework of services of our National Health System the pharmacological innovation, diagnostic information of the associated biomarker and the attention to patients with the specific pharmacy that the system is much more efficient and more sustainable. “Who has to deal with what he has to deal with”, said doctor Álvaro Rodríguez-Lescure.

“I do not want to say that in Spain it does not happen, that it does not have a coordinated plan as it has in other countries that, frankly, has a lot of help to log transfer this innovation in equal conditions to patients. In this sense , recalls here that access to the Personalized Medicine has become equitable, Independent living donation or the hospital that treats the patient. the doctor Luis Paz-Ares.

For this, he insisted that “the development of Precision Medicine requires an intersectoral collaboration of different actors such as scientists and their scientific societies, clinical oncologists and with the competition of the Ministry of Health”. “translate into national strategic plans that require its implementation in terms of full equity in all national territory”, the President of SEOM recalled.

He also presented a video where he was able to read the record of innovation in cancer, from which he initiated the basic investigation in the laboratory, continues with the clinical investigation in the hospitals and which culminates in the application of the hallucinations to cancer patients, all explained with the intervention of a basic investigator, a clinical investigator and a patient. The video also recounts the testimony of a patient who, like the Personalized Medicine, allowed significant advances in the treatment of his cancer.

Source